Skip to content
MedsAcross

Medicine

Avance Nerve Graft 2 mm/15 mm implant

Human peripheral nerve tissue · Soft tissue · Axogen
Available on requestPrescription onlyUS FDA Cold chain

Avance Nerve Graft 2 mm/15 mm implant is a prescription medicine containing Human peripheral nerve tissue for soft tissue use, marketed by Axogen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Once thawed, it should not be placed back into the freezer. Store AVANCE at…

Key facts

Active ingredient (INN)
Human peripheral nerve tissue
Brand
Avance Nerve Graft
Strength
2 mm/15 mm
Dosage form
Implant
Route
Soft tissue
Packs
1 carton
Marketing authorisation holder
Axogen
Manufacturer
Axogen
Origin register
US FDA, United States
Storage
Once thawed, it should not be placed back into the freezer. Store AVANCE at ≤-40°C (≤-40°F) and keep frozen until use. • Do not use AVANCE if any component of the immediate container closure system or commercial carton has been compromised. • Thaw AVANCE to room temperature without heating using room temperature sterile normal saline or Lactated Ringer’s Solution (LRS).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3002.15Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
6 April 2026
Identifiers
RxCUI 2749421, 2749427DailyMed set ID e50d90fa-83ef-4d1b-9691-2b9c7bbdc2aeNDC 84545-215, 84545-430Application BLA125816

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 carton in 1 bag / 1 pouch in 1 carton / 1 pouch in 1 pouch / 1 container in 1 pouch / 1 mm in 1 container84545-215-01Axogen6 April 2026
1 carton in 1 bag / 1 pouch in 1 carton / 1 pouch in 1 pouch / 1 container in 1 pouch / 1 mm in 1 container84545-430-01Axogen6 April 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Human peripheral nerve tissue

Clinical summary

Human peripheral nerve tissue is a prescription medicine indicated for the treatment of adult and pediatric patients aged one month and older with sensory nerve discontinuity (≤25 mm), among other approved uses. MedsAcross supplies Human peripheral nerve tissue for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Human peripheral nerve tissue

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Avance Nerve Graft 2 mm/15 mm implant for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.